Hoping to forestall a congressional probe, the St. Regis Mohawk Tribe sent an angry letter to the U.S. Senate Judiciary Committee complaining that criticism of its controversial deal to obtain valuable patents from Allergan (AGN) is misguided, inaccurate, and unfair. Several lawmakers have denounced the deal as a cynical maneuver designed to thwart competition from lower-cost generic medicines.

In arguing against an inquiry, the tribal leaders wrote the committee that the federal government “should not force Indian Country to bear the consequences of partisan disagreements about how to control drug prices and deliver affordable healthcare.” And they insisted the government should fix pollution problems harming the tribe, rather than scrutinize a deal that provides needed revenue.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy